Serum Beclin 1 and autophagy-related protein-5 and the risk of hepatocellular carcinoma among cirrhotic hepatitis C patients

Egyptian Liver Journal

Table 6 Comparison between the three studied groups according to BECLIN1

BECLIN1 (ng/ml)	Cirrhotic	HCC	Control	H	p
BECLIN1 (ng/ml)	(n = 30)	(n = 30)	(n = 20)	H	p
Min. – Max	1.20–12.0	3.90 – 19.80	0.70–13.60	22.344^*	< 0.001^*
Mean ± SD	5.62 ± 2.46	8.65 ± 3.30	4.49 ± 3.06
Median	5.25	7.90	4.70
IQR	4.15 – 6.95	6.20 – 10.40	3.10 – 6.60
Sig. bet. grps	p₁ < 0.001^, p₂ = 0.200, p₃ = 0.001^

H: H for Kruskal Wallis test, Pairwise comparison bet. each 2 groups were done using Post Hoc Test (Dunn's for multiple comparisons test)
p: p value for comparing between the studied groups
p₁: p value for comparing between Cirrhotic and HCC
p₂: p value for comparing between Cirrhotic and Control
p₃: p value for comparing between HCC and Control
^*: Statistically significant at p ≤ 0.05